- Home
- INMB vs MATH Comparison
INMB vs MATH Comparison
Compare INMB & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- MATH
- Stock Information
- Founded
- INMB 2015
- MATH 2015
- Country
- INMB United States
- MATH Hong Kong
- Employees
- INMB N/A
- MATH N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- MATH Finance/Investors Services
- Sector
- INMB Health Care
- MATH Finance
- Exchange
- INMB Nasdaq
- MATH Nasdaq
- Market Cap
- INMB 53.4M
- MATH 60.8M
- IPO Year
- INMB 2019
- MATH N/A
- Fundamental
- Price
- INMB $1.91
- MATH $3.35
- Analyst Decision
- INMB Buy
- MATH
- Analyst Count
- INMB 4
- MATH 0
- Target Price
- INMB $9.53
- MATH N/A
- AVG Volume (30 Days)
- INMB 822.2K
- MATH 152.2K
- Earning Date
- INMB 10-30-2025
- MATH 10-30-2025
- Dividend Yield
- INMB N/A
- MATH N/A
- EPS Growth
- INMB N/A
- MATH N/A
- EPS
- INMB N/A
- MATH 0.41
- Revenue
- INMB $50,000.00
- MATH $44,567,257.00
- Revenue This Year
- INMB $142.83
- MATH N/A
- Revenue Next Year
- INMB $14,780.90
- MATH N/A
- P/E Ratio
- INMB N/A
- MATH $8.22
- Revenue Growth
- INMB N/A
- MATH 165.86
- 52 Week Low
- INMB $1.71
- MATH $0.88
- 52 Week High
- INMB $11.64
- MATH $4.17
- Technical
- Relative Strength Index (RSI)
- INMB 38.01
- MATH 55.21
- Support Level
- INMB $1.71
- MATH $2.96
- Resistance Level
- INMB $2.12
- MATH $3.65
- Average True Range (ATR)
- INMB 0.12
- MATH 0.26
- MACD
- INMB 0.04
- MATH 0.04
- Stochastic Oscillator
- INMB 45.45
- MATH 64.71
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.